Cullinan Associates Inc. Has $7.54 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cullinan Associates Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.2% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,388 shares of the healthcare conglomerate's stock after selling 4,110 shares during the period. Cullinan Associates Inc.'s holdings in UnitedHealth Group were worth $7,536,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $27,233,000. Revolve Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG increased its holdings in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after buying an additional 9,872 shares in the last quarter. Finally, Blackston Financial Advisory Group LLC increased its holdings in shares of UnitedHealth Group by 12.8% during the fourth quarter. Blackston Financial Advisory Group LLC now owns 1,086 shares of the healthcare conglomerate's stock worth $549,000 after buying an additional 123 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $302.04 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $273.99 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.42 and a beta of 0.44. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a 50-day simple moving average of $359.15 and a 200 day simple moving average of $462.77.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the firm earned $6.91 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Insider Buying and Selling

In related news, Director Kristen Gil acquired 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

UNH has been the subject of several recent analyst reports. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Barclays decreased their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Raymond James Financial cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Finally, Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $427.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.